U.S. Markets closed
  • S&P Futures

    4,052.75
    -4.75 (-0.12%)
     
  • Dow Futures

    32,871.00
    -32.00 (-0.10%)
     
  • Nasdaq Futures

    12,934.50
    -30.50 (-0.24%)
     
  • Russell 2000 Futures

    1,781.20
    -3.10 (-0.17%)
     
  • Crude Oil

    72.96
    -0.01 (-0.01%)
     
  • Gold

    1,962.30
    -4.60 (-0.23%)
     
  • Silver

    23.42
    -0.05 (-0.20%)
     
  • EUR/USD

    1.0847
    0.0000 (-0.0000%)
     
  • 10-Yr Bond

    3.5660
    +0.0020 (+0.06%)
     
  • Vix

    19.12
    -0.85 (-4.26%)
     
  • GBP/USD

    1.2306
    -0.0006 (-0.0505%)
     
  • USD/JPY

    132.5120
    -0.2330 (-0.1755%)
     
  • BTC-USD

    28,372.57
    +1,098.62 (+4.03%)
     
  • CMC Crypto 200

    617.71
    +16.74 (+2.79%)
     
  • FTSE 100

    7,564.27
    +80.02 (+1.07%)
     
  • Nikkei 225

    27,883.78
    0.00 (0.00%)
     

Why Compugen Stock Crumbled Today

Stocks in the ever-volatile biotech sector have many ups and downs, and Monday wasn't one of the ups for Compugen (NASDAQ: CGEN). The cancer treatment developer published its latest set of quarterly results, and investors showed their displeasure by trading the company's shares down by over 9%. Before market open, Compugen presented its third-quarter figures.